These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23353717)

  • 1. Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study.
    Park DS; Oh JJ; Hong JY; Hong YK; Choi DK; Gong IH; Hwang JH; Kwon SW
    Asian J Androl; 2013 Mar; 15(2):249-53. PubMed ID: 23353717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia.
    Mochtar CA; Kiemeney LA; van Riemsdijk MM; Barnett GS; Laguna MP; Debruyne FM; de la Rosette JJ
    Eur Urol; 2003 Dec; 44(6):695-700. PubMed ID: 14644122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Calculator for Estimating Prostate Volume in Daily Urology Services.
    Lim J; Rampal S; Razack AHA; Malek R; Sundram M; Nasuha NA; Ooi CC; Ong TA; Sothilingam S
    Urology; 2018 Aug; 118():145-151. PubMed ID: 29746873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serum prostate specific antigen level and prostate volume in a community-based cohort: large-scale screening of 35,223 Korean men.
    Park DS; Hong JY; Hong YK; Lee SR; Hwang JH; Kang MH; Kwon SW; Oh JJ
    Urology; 2013 Dec; 82(6):1394-9. PubMed ID: 24295251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prostate-specific antigen as a predictor of prostate volume in Korean men with lower urinary tract symptoms.
    Shim HB; Lee JK; Jung TY; Ku JH
    Prostate Cancer Prostatic Dis; 2007; 10(2):143-8. PubMed ID: 17199133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
    Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and total and free prostate-specific antigen levels for predicting prostate volume in patients with benign prostatic hyperplasia.
    Coban S; Doluoglu OG; Keles I; Demirci H; Turkoglu AR; Guzelsoy M; Karalar M; Demirbas M
    Aging Male; 2016 Jun; 19(2):124-7. PubMed ID: 26872869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study.
    Bohnen AM; Groeneveld FP; Bosch JL
    Eur Urol; 2007 Jun; 51(6):1645-52; discussion 1652-3. PubMed ID: 17320271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up.
    Yang TK; Woo P; Yang HJ; Chang HC; Hsieh JT; Huang KH
    PLoS One; 2016; 11(1):e0145050. PubMed ID: 26731481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
    Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
    Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which obesity index best correlates with prostate volume, prostate-specific antigen, and lower urinary tract symptoms?
    Yang HJ; Doo SW; Yang WJ; Song YS
    Urology; 2012 Jul; 80(1):187-90. PubMed ID: 22626573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.
    Berges R; Oelke M
    World J Urol; 2011 Apr; 29(2):171-8. PubMed ID: 21221974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.
    Li BH; Deng T; Huang Q; Zi H; Weng H; Zeng XT
    Am J Mens Health; 2019; 13(4):1557988319870382. PubMed ID: 31426706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms.
    Russo GI; Castelli T; Privitera S; Fragalà E; Favilla V; Reale G; Urzì D; La Vignera S; Condorelli RA; Calogero AE; Cimino S; Morgia G
    BJU Int; 2015 Nov; 116(5):791-6. PubMed ID: 25601421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.
    Abotsi E; Adanu KK; Bansah EC
    Afr J Prim Health Care Fam Med; 2022 Dec; 14(1):e1-e6. PubMed ID: 36546488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.